The effect of periodontal therapy on C-reactive protein, endothelial function, lipids and proinflammatory biomarkers in patients with stable coronary artery disease: study protocol for a randomized controlled trial

Trials

Alex Nogueira Haas³  Cassiano Kuchenbecker Rösing³  Carisi Anne Polanczyk¹  Eneida Rejane Rabelo-Silva²  Cassio Kampits³  Ingrid Webb Josephson Ribeiro³  Márlon Munhoz Montenegro³  Mariana Vargas Furtado¹  Marco Aurélio Lumertz Saffi² 

[1] Institute for Health Technology Assessment (IATS-CNPq), Ramiro Barcelos 2350, Porto Alegre, Brazil;Hospital de Clínicas de Porto Alegre, Cardiology Division, School of Medicine, Federal University of Rio Grande do Sul, Ramiro Barcelos 2350, Porto Alegre, Brazil;Faculty of Dentistry, Periodontology, Federal University of Rio Grande do Sul, Ramiro Barcelos 2492, Porto Alegre 90035-003, Brazil

关键词: Lipids;    Endothelial function;    Randomized controlled trial;    Coronary artery disease;    Non-surgical periodontal therapy;    C-reactive protein;    Cardiovascular diseases;    Periodontal diseases;   

Others  :  1093105
DOI  :  10.1186/1745-6215-14-283

 received in 2013-06-19, accepted in 2013-09-03,  发布年份 2013

【 摘 要 】

Background

Scarce information exists regarding the preventive effect of periodontal treatment in the recurrence of cardiovascular events. Prevention may be achieved by targeting risk factors for recurrent coronary artery disease (CAD) in patients with previous history of cardiovascular events. The aim of this trial is to compare the effect of two periodontal treatment approaches on levels of C-reactive protein, lipids, flow-mediated dilation and serum concentrations of proinflammatory and endothelial markers in stable CAD patients with periodontitis over a period of 12 months.

Methods/design

This is a randomized, parallel design, examiner blinded, controlled clinical trial. Individuals from both genders, 35 years of age and older, with concomitant diagnosis of CAD and periodontitis will be included. CAD will be defined as the occurrence of at least one of the following events 6 months prior to entering the trial: documented history of myocardial infarction; surgical or percutaneous myocardial revascularization and lesion >50% in at least one coronary artery assessed by angiography; presence of angina and positive noninvasive testing of ischemia. Diagnosis of periodontitis will be defined using the CDC-AAP case definition (≥2 interproximal sites with clinical attachment loss ≥6 mm and ≥1 interproximal site with probing depth ≥5 mm). Individuals will have to present at least ten teeth present to be included. One hundred individuals will be allocated to test (intensive periodontal treatment comprised by scaling and root planing) or control (community periodontal treatment consisting of one session of supragingival plaque removal only) treatment groups. Full-mouth six sites per tooth periodontal examinations and subgingival biofilm samples will be conducted at baseline, 3, 6 and 12 months after treatment. The primary outcome of this study will be C-reactive protein changes over time. Secondary outcomes include levels of total cholesterol, LDL-C, HDL-C, triglycerides, IL-1β, IL-6, TNFα, fibrinogen, ICAM-1, VCAM-1 and E-selectin. These outcomes will be assessed at all time points over 12 months. Flow-mediated dilation will be assessed at baseline, 1, 3 and 6 months after periodontal therapy.

Discussion

This trial will provide new evidence regarding the effect of periodontal treatment on risk markers for recurrence of cardiovascular events in stable coronary artery disease patients.

Trial registration number

ClinicalTrials.gov Identifier, NCT01609725

【 授权许可】

   
2013 Saffi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]The top 10 causes of death http://who.int/mediacentre/factsheets/fs310/en/ webcite
• [2]Packard RR, Libby P: Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54:24-38.
• [3]Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
• [4]van Holten TC, Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW, Roest M: Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PloS One 2013, 8:e62080.
• [5]Blaizot A, Vergnes JN, Nuwwareh S, Amar J, Sixou M: Periodontal diseases and cardiovascular events: meta-analysis of observational studies. Int Dent J 2009, 59:197-209.
• [6]Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE, Roberts WC, et al.: The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol 2009, 80:1021-1032.
• [7]Mustapha IZ, Debrey S, Oladubu M, Ugarte R: Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol 2007, 78:2289-2302.
• [8]Khader YS, Albashaireh ZS, Alomari MA: Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysis. J Periodontol 2004, 75:1046-1053.
• [9]Beck JD, Offenbacher S: The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol 2001, 6:9-15.
• [10]Tonetti MS, Van Dyke TE, Working group 1 of the joint EFPAAPw: Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAPWorkshop on Periodontitis and Systemic Diseases. J Periodontol 2013, 84:S24-S29.
• [11]Bahekar AA, Singh S, Saha S, Molnar J, Arora R: The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007, 154:830-837.
• [12]Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, et al.: Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 2012, 125:2520-2544.
• [13]Paraskevas S, Huizinga JD, Loos BG: A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008, 35:277-290.
• [14]D’Aiuto F, Orlandi M, Gunsolley JC: Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Periodontol 2013, 84:S85-S105.
• [15]Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R, Kebschull M, Belusko PB, Herrera-Abreu M, Lalla E, Papapanou PN: Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009, 36:287-294.
• [16]Buhlin K, Hultin M, Norderyd O, Persson L, Pockley AG, Rabe P, Klinge B, Gustafsson A: Risk factors for atherosclerosis in cases with severe periodontitis. J Clin Periodontol 2009, 36:541-549.
• [17]Lopez-Jornet P, Berna-Mestre JD, Berna-Serna JD, Camacho-Alonso F, Fernandez-Millan S, Reus-Pintado M: Measurement of atherosclerosis markers in patients with periodontitis: a case–control study. J Periodontol 2012, 83:690-698.
• [18]Mercanoglu F, Oflaz H, Oz O, Gokbuget AY, Genchellac H, Sezer M, Nisanci Y, Umman S: Endothelial dysfunction in patients with chronic periodontitis and its improvement after initial periodontal therapy. J Periodontol 2004, 75:1694-1700.
• [19]Li X, Tse HF, Yiu KH, Jia N, Chen H, Li LS, Jin L: Increased levels of circulating endothelial progenitor cells in subjects with moderate to severe chronic periodontitis. J Clin Periodontol 2009, 36:933-939.
• [20]Lucarini G, Zizzi A, Aspriello SD, Ferrante L, Tosco E, Lo Muzio L, Foglini P, Mattioli-Belmonte M, Di Primio R, Piemontese M: Involvement of vascular endothelial growth factor, CD44 and CD133 in periodontal disease and diabetes: an immunohistochemical study. J Clin Periodontol 2009, 36:3-10.
• [21]Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C, Melandri G: Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J Clin Periodontol 2005, 32:188-192.
• [22]Vidal F, Figueredo CM, Cordovil I, Fischer RG: Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 2009, 80:786-791.
• [23]Ramirez JH, Arce RM, Contreras A: Periodontal treatment effects on endothelial function and cardiovascular disease biomarkers in subjects with chronic periodontitis: protocol for a randomized clinical trial. Trials 2011, 12:46. BioMed Central Full Text
• [24]Cardiologia SBd: IV Guidelines of Sociedade Brasileira de Cardiologia for Treatment of Acute Myocardial Infarction with ST-segment elevation. Arq Bras Cardiol 2009, 93:e179-e264.
• [25]Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ: Update of the case definitions for population-based surveillance of periodontitis. J Periodontol 2012, 83:1449-1454.
• [26]Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al.: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39:257-265.